Chemotherapy-induced acral erythema: report of a case and immunohistochemical findings

被引:11
作者
Tsuruta, D
Mochida, K
Hamada, T
Ishii, M
Wakasa, K
Hashimoto, S
Takekawa, KE
机构
[1] Osaka City Univ, Sch Med, Dept Dermatol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Sch Med, Dept Haematol, Abeno Ku, Osaka 5458585, Japan
[3] Osaka City Univ Hosp, Dept Pathol, Osaka, Japan
[4] Teramoto Mem Hosp, Div Internal Med, Osaka, Japan
关键词
D O I
10.1046/j.1365-2230.2000.00670.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Chemotherapy-induced acral erythema (CAE) is an uncommon and distinct reaction seen in patients receiving high-dose chemotherapy. The exact pathogenic mechanisms of this disorder are still unknown. We report a 27-year-old woman who presented with red, swollen and painful macules on both palms, clinically consistent with this disease. Histological examination demonstrated vacuolar degeneration of the basal cell layer and spongiotic blisters in the epidermis, especially in the atrophied eccrine ducts and papillary oedema with mild perivascular infiltration of mononuclear and hypersegmented neutrophils. Immunohistochemistry showed that the infiltrating mononuclear cells were CD3-CD16+CD56+ leucocyte function antigen-1+, possibly natural killer cells. The eccrine ducts expressed HLA-DR and intracellular adhesion molecule-1 (ICAM-1). Our findings suggest that cell-to-cell interaction between NK cells and keratinocytes in the eccrine apparatus may induce CAE and may be involved in the pathogenesis of the skin reaction in our patient and possibly in this disease.
引用
收藏
页码:386 / 388
页数:3
相关论文
共 10 条
[1]   IDENTIFICATION OF NATURAL-KILLER (NK) CELLS IN LESIONS OF HUMAN CUTANEOUS GRAFT-VERSUS-HOST DISEASE - EXPRESSION OF A NOVEL NK-ASSOCIATED SURFACE-ANTIGEN (KP43) IN MONONUCLEAR INFILTRATES [J].
ACEVEDO, A ;
ARAMBURU, J ;
LOPEZ, J ;
FERNANDEZHERRERA, J ;
FERNANDEZRANADA, JM ;
LOPEZBOTET, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (04) :659-666
[2]   CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA [J].
BAACK, BR ;
BURGDORF, WHC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (03) :457-461
[3]   SYRINGOSQUAMOUS METAPLASIA - A DISTINCTIVE ERUPTION IN PATIENTS RECEIVING CHEMOTHERAPY [J].
BHAWAN, J ;
MALHOTRA, R .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (01) :1-6
[4]   PECULIAR ACRAL ERYTHEMA SECONDARY TO HIGH-DOSE CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA [J].
BURGDORF, WHC ;
GILMORE, WA ;
GANICK, RG .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :61-62
[5]   CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA IN PATIENTS RECEIVING BONE-MARROW TRANSPLANTATION [J].
CRIDER, MK ;
JANSEN, J ;
NORINS, AL ;
MCHALE, MS .
ARCHIVES OF DERMATOLOGY, 1986, 122 (09) :1023-1027
[6]   Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases [J].
Demircay, Z ;
Gurbuz, O ;
Alpdogan, TB ;
Yucelten, D ;
Alpdogan, O ;
Kurtkaya, O ;
Bayik, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (08) :593-598
[7]   ECCRINE SQUAMOUS SYRINGOMETAPLASIA - A CUTANEOUS SWEAT GLAND REACTION IN THE HISTOLOGIC SPECTRUM OF CHEMOTHERAPY-ASSOCIATED ECCRINE HIDRADENITIS AND NEUTROPHILIC ECCRINE HIDRADENITIS [J].
HURT, MA ;
HALVORSON, RD ;
PETR, FC ;
COOPER, JT ;
FRIEDMAN, DJ .
ARCHIVES OF DERMATOLOGY, 1990, 126 (01) :73-77
[8]  
LEVINE LE, 1985, ARCH DERMATOL, V121, P1240
[9]   CHEMOTHERAPY-ASSOCIATED PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME [J].
LOKICH, JJ ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (06) :798-800
[10]  
RAYNAERT H, 1992, BONE MARROW TRANSPL, V10, P185